The largest database of trusted experimental protocols

Pmirglo dual luciferase mirna target expression reporter

Manufactured by Promega
Sourced in United States

The PmiRGLO dual-luciferase miRNA target expression reporter is a plasmid-based system designed to study miRNA-target interactions. It contains a Renilla luciferase gene that serves as a control for normalizing transfection efficiency, and a firefly luciferase gene whose expression is regulated by the 3' UTR of a potential miRNA target. This system allows for the quantitative analysis of miRNA activity on a specific target.

Automatically generated - may contain errors

4 protocols using pmirglo dual luciferase mirna target expression reporter

1

Dual-Luciferase Assay for miRNA Target Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type (WT) or mutant type (MUT) circ_0001023 sequences were subcloned into pmiRGLO dual-luciferase miRNA target expression reporter (Promega, Madison, WI, USA). MiR-409-3p or miR-con were co-transfected with WT or MUT reporters into GC cells, respectively. Luciferase activity was measured 48 hours after transfection. Dual-luciferase reporter assay system (Promega, Madison, WI, USA) was adopted to determine the luciferase activity, and firefly luciferase activity was normalized to renilla luciferase activity.
+ Open protocol
+ Expand
2

Dual-Luciferase Assay for GATA6-AS1 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type GATA6-AS1 and mutant GATA6-AS1 fragments containing the predicted binding sites were constructed and integrated into the pmiRGLO dual-luciferase miRNA target expression reporter (Promega, Madison, WI, USA) to construct GATA6-AS1 wild type (GATA6-AS1-WT) reporter and GATA6-AS1-mutant (GATA6-AS1-MUT) reporter vectors. GATA6-AS1-WT reporter or GATA6-AS1-MUT reporter, together with miR-543 mimics or negative control miRNA, was transfected into H1299 and H460 cells. 48 h after transfection, the luciferase activity of each group was determined according to the instructions of dual-luciferase reporter assay system (Promega, Madison, WI, USA), and the firefly luciferase activity was normalized to renilla luciferase activity.
+ Open protocol
+ Expand
3

Validating miR-582-5p Binding to circ-ACACA and ERO1A

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding site between circ-ACACA and miR-582-5p as well as miR-582-5p and ERO1A was predicted using the Encyclopedia of RNA Interactomes (ENCORI) database (http://starbase.sysu.edu.cn/). To validate the binding relationship between miR-582-5p and circ-ACACA or ERO1A, wild-type (WT) or mutant (MUT) 3-untranslated region sequences of circ-ACACA or ERO1A were cloned into a pmiRGLO dual-luciferase miRNA target expression reporter (Promega Corporation). HeLa cells were subsequently transfected with miR-582-5p mimic or mimic-NC and WT or MUT reporters using Lipofectamine® 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.). The relative luciferase activity was measured at 48 h post-transfection using a Dual Luciferase Reporter assay system (Promega Corporation). And firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
4

Predicting miR-103 Binding to OTUD7B 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bioinformatics was utilized to predict the potential binding sites between 3′-UTR of OTUD7B and miR-103. The OTUD7B 3′-UTR wild sequence or OTUD7B 3′-UTR mutant sequence was inserted into the pmiRGLO dualluciferase miRNA target expression reporter (Promega, Madison, WI, USA). 293T cells were seeded on 24-well plates (5 × 10 5 cells / well) and 24 h later, the cells were co-transfected with luciferase reporters and miR-103 mimic or negative control mimic using with Lipofectamine® 2000 (Invitrogen, Carlsbad, CA, USA). The luciferase activity was detected 48 h after transfection with Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) in accordance with the manufacturer's instructions. NF-κB luciferase reporter plasmid (Beyotime Institute of Biotechnology, Nantong, Jiangsu, China) with OTUD7B plasmid or OTUD7B shRNA were co-transfected into NHL using Lipofectamine® 2000 (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. After 24 h, luciferase activity was measured using the luciferase kit (Beyotime, Hangzhou, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!